Prague Med. Rep. 2022, 123, 27-34
https://doi.org/10.14712/23362936.2022.3
POEMS Syndrome Diagnosis in a Patient with Mixed Polyneuropathy: Case Report
References
1. , A., Hayman, S. R., Buadi, F., Mauermann, M., Lacy, M. Q., Gertz, M. A., Kyle, R. A., Kumar, S., Greipp, P. R., Lust, J. A., Zeldenrust, S., Witzig, T. E., Raikumar, S. V., Dispinzeri, A. (2011) The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood 118(17), 4663–4665.
<https://doi.org/10.1182/blood-2011-06-362392>
2. , L. N., Hanson, C. A., Dispenzieri, A., Morice, W. G., Kurtin, P. J., Hoyer, J. D. (2011) Bone marrow histopathology in POEMS syndrome: A distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. Blood 117(24), 6438–6444.
<https://doi.org/10.1182/blood-2010-11-316935>
3. , A. (2017) POEMS syndrome: 2017 update on diagnosis, risk stratification, and management. Am. J. Hematol. 92(8), 814–829.
<https://doi.org/10.1002/ajh.24802>
4. , A., Kyle, R. A., Lacy, M. Q., Rajkumar, S. V., Therneau, T. M., Larson, D. R., Greipp, P. R., Witzig, T. E., Basu, R., Suarez, G. A., Fonseca, R., Lust, J. A., Gertz, M. A. (2003) POEMS syndrome: Definitions and long-term outcome. Blood 101(7), 2496–2506.
<https://doi.org/10.1182/blood-2002-07-2299>
5. , R. K., Bélec, L., Soubrier, M., Malapert, D., Zuber, M., Viard, J. P., Intrator, L., Degos, J. D., Authier, F. J. (1996) Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 87(4), 1458–1465.
<https://doi.org/10.1182/blood.V87.4.1458.bloodjournal8741458>
6. , S., D’sa, S., Foldes, D., Carr, A. S., Reilly, M. M., Lunn, M. P. T. (2018) POEMS neuropathy: Optimising diagnosis and management. Pract. Neurol. 18(4), 278–290.
<https://doi.org/10.1136/practneurol-2017-001792>
7. Kuwabara, S., Dispenzieri, A., Arimura, K., Misawa, S., Nakaseko, C. (2012) Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane Database Syst. Rev. 2012(6), CD006828.
8. , K., Umehara, F., Hashiguchi, T., Arimura, K., Matsuura, E., Watanabe, O., Fujimoto, N., Okada, Y., Osame, M. (2001) Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome. Neurology 56(6), 807–810.
<https://doi.org/10.1212/WNL.56.6.807>
9. , S., Misawa, S., Sekiguchi, Y., Shibuya, K., Kanai, K., Fujimaki, Y., Ohmori, S., Mitsuma, S., Koga, S., Kuwabara, S. (2012) Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Neurosurg. Psychiatry 83(5), 476–479.
<https://doi.org/10.1136/jnnp-2011-301706>
10. , C., Arquero, R., García-Raso, A., Llamas, P. (2016) Diagnóstico de síndrome de POEMS tras neuropatía de larga evolución. Neurologia (Barcelona, Spain) 34(4), 272–274.
<https://doi.org/10.1016/j.nrl.2016.08.011>
11. , T., Misawa, S., Beppu, M., Takahashi, S. (2019) Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey. Neurology 93(10), 975–984.
<https://doi.org/10.1212/WNL.0000000000008062>
12. , J. M., Jauberteau, M. O., Bordessoule, D., Yardin, C., Preux, P. M., Couratier, P. (1996) Link between peripheral neuropathy and monoclonal dysglobulinemia: A study of 66 cases. J. Neurol. Sci. 137(2), 124–130.
<https://doi.org/10.1016/0022-510X(95)00343-Z>
13. , O., Arimura, K., Kitajima, I., Osame, M., Maruyama, I. (1996) Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347(9002), 702.
<https://doi.org/10.1016/S0140-6736(96)91261-1>
